Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faye Vazvaei-Smith

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The AAPS Journal|September 12, 2024
ICH M10 Bioanalytical Method Validation Guideline-1 year LaterFaye Vazvaei-Smith, Enaksha Wickremsinhe, Eric Woolf, et al.
Bioanalysis|February 18, 2026
Strategy for streamlining antibody-drug conjugate pharmacokinetic assaysWeifeng Xu, Linlin Luo, Murali Matta, et al.
Bioanalysis|January 8, 2026
Streamlined neutralizing antibody assay development: overcoming serum interference, utilization of DOE and automationKelly Ngoc Pham, Nazneen Bano, Leonard J Rubinstein, et al.
The AAPS Journal|May 9, 2022
Biomarker Assay Validation by Mass SpectrometryCarmen Fernández-Metzler, Brad Ackermann, Fabio Garofolo, et al.
The AAPS Journal|September 27, 2022
Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data AnalysisWeifeng Xu, Brian Maas, Brad Roadcap, et al.
Clinical Pharmacology and Therapeutics|December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working GroupWenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
The AAPS Journal|March 12, 2025
Best Practices and Recommendations for Non-Liquid Matrices BioanalysisFaye Vazvaei-Smith, Wenkui Li, Omar S Barnaby, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The AAPS Journal|September 12, 2024
ICH M10 Bioanalytical Method Validation Guideline-1 year LaterFaye Vazvaei-Smith, Enaksha Wickremsinhe, Eric Woolf, et al.
Bioanalysis|February 18, 2026
Strategy for streamlining antibody-drug conjugate pharmacokinetic assaysWeifeng Xu, Linlin Luo, Murali Matta, et al.
Bioanalysis|January 8, 2026
Streamlined neutralizing antibody assay development: overcoming serum interference, utilization of DOE and automationKelly Ngoc Pham, Nazneen Bano, Leonard J Rubinstein, et al.
The AAPS Journal|May 9, 2022
Biomarker Assay Validation by Mass SpectrometryCarmen Fernández-Metzler, Brad Ackermann, Fabio Garofolo, et al.
The AAPS Journal|September 27, 2022
Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data AnalysisWeifeng Xu, Brian Maas, Brad Roadcap, et al.
Clinical Pharmacology and Therapeutics|December 11, 2023
Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working GroupWenkui Li, Faye Vazvaei-Smith, Gordon Dear, et al.
The AAPS Journal|March 12, 2025
Best Practices and Recommendations for Non-Liquid Matrices BioanalysisFaye Vazvaei-Smith, Wenkui Li, Omar S Barnaby, et al.
Pageof 1